Mayo Clinic in Florida
Jacksonville, Florida, 32224, United States
NCT Number: NCT04002583
Researchers are trying to determine the frequency of seizures and epilepsy in patients with Early-onset Alzheimer's disease (EOAD) using a 48-hour computer assisted ambulatory electroencephalogram.
This study is active but is not currently recruiting participants.
Notify Me40 year–64 year
All sexes
Interventional
Not applicable
Jacksonville, Florida, 32224, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for EOAD patients will be recruited from the LEADS trial with the following:
Exclusion criteria
A portable 16 channel CAA-EEG is used to detect epileptiform abnormalities in a 48 hour ambulatory electroencephalogram (EEG)
Other names: CAA-EEG
Time frame: 48 hours
Number of subjects with electrographic seizures in 48 hours on computer assisted ambulatory EEG
Mayo Clinic
Other
A Prospective Study Evaluating the Use of 48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07564700
Alzheimer Disease, Alzheimer Disease (AD)
Düsseldorf, North Rhine-Westphalia, Germany
View Trial DetailsNCT03507257
Alzheimer Disease, Brain Diseases
Sun City, Arizona, United States
View Trial DetailsNCT07294586
Alzheimer Disease, Brain Diseases
Colmar, Alsace, France
View Trial DetailsNCT03634007
Alzheimer Disease, Brain Diseases
Maitland, Florida, United States
View Trial Details